Friday, January 9, 2009
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


FDA Licenses For Marketing New Therapy For Rare Genetic Disease
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Mon, 13 Oct 2008 05:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/125280.php
FDA Licenses For Marketing New Therapy For Rare Genetic DiseaseThe U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
Click here for full Story
http://www.medicalnewstoday.com/articles/125280.php
Bookmark this news story online:
Add FDA Licenses For Marketing New Therapy For Rare Genetic Disease to BlinkListAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to DeliciousAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to DiggAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to FarkAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to FurlAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to BlogarithmAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to MeneameAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to My Yahoo!Add FDA Licenses For Marketing New Therapy For Rare Genetic Disease to ReddItAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to ShadowsAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to SimpyAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to SpurlAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Sync2ItAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to MagnoliaAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to NewsVineAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Ask Jeeves
Add FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Raw SugarAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to DiigoAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to NetVouzAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Stumble UponAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to SegnaloAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Google BookmarksAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Microsoft LiveAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to BlogMarksAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to WinkAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to TechnoratiAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Feed Me LinksAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to LinkaGoGoAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to BlueDotAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Mister WongAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to TailRankAdd FDA Licenses For Marketing New Therapy For Rare Genetic Disease to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Perfectionist Protein-Maker Trashes Errors
bullet Unibioscreen Announces Progress Of Phase I Clinical Trial For UNBS1450 In Europe In Cancer Patients With Advanced Solid Tumors
bullet Excessive Use Of Antiviral Drugs Could Aid Deadly Flu According To Study
bullet Don't Let 'iPatient' Detract From Hands-On Medicine, Stanford Author/Educator Urges
bullet Absence Of CLP Protein Can Be Indicative Of Oral Cancer
bullet U.S. Patent And Trademark Office Accepts Pfizer's Reissue Application On Lipitor Enantiomer Patent
bullet Target Discovered That Could Ease Spinal Muscular Atrophy Symptoms
bullet BASi Receives A European Patent For Culex(R)
bullet Winter Babies Face Socioeconomic Disadvantages
bullet Xenomics, Inc. Discusses HPV Screening Test Based On Transrenal DNA Technology At 52nd All India Congress Of Obstetrics & Gynecology
bullet Court Rules In Favor Of Medtronic In Fidelis Litigation
bullet Human Genomics In China
bullet The MDS Foundation Says VIDAZA Approval In Europe Could Provide Survival Benefits To Patients With Myelodysplastic Syndromes And Related Cancers
bullet Initial Findings Could Lead To A New Approach For Treating Fragile X Syndrome
bullet Advaxis' Phase II Clinical Trial "HOLD" Lifted
bullet Women's Access To Donated Kidneys Declines With Age, Particularly Compared With Men
bullet Cameron Health Commences Clinical Trial Of The Minimally Invasive Totally Subcutaneous Implantable Defibrillator For Treatment Of SCA
bullet Avian Flu Becoming More Resistant To Antiviral Drugs, Says University Of Colorado Study
bullet New Test Will Catch Sports Cheats On New Endurance Drugs
bullet Mountaineers Measure Lowest Human Blood Oxygen Levels On Record
bullet HHS Issues Action Plan To Prevent Health Care-Associated Infections
bullet Health Care Delivery Could Be Adversely Affected By Cost Containment Focus
bullet QuantRx(R) Announces FDA 510(k) Clearance For Its RapidSense(R) Methamphetamine Test
bullet HWI Scientist First In World To Unravel Structure Of Key Breast Cancer Target Enzyme
bullet KineMed Awarded Michael J. Fox Foundation Funding To Validate Translational Biomarker Of Microtubule Function In Parkinson's Disease
 
© 2007 Verge Systems